|
Osteotech, Inc. - Comparative Business Analysis Snapshot
Business Description
Osteotech, Inc.. The Group's principal activities are processing of human bone and connective tissue technologies for transplants and developing, manufacturing, and marketing biologic, biomaterial and device systems for musculoskeletal surgery. It has four operating segments: Demineralized Bone Matrix (DBM), Traditional Tissue, Spinal Allograft, Client Services and Hybrid/Synthetics. The DBM Segment provides processing and marketing of 'Grafton' and private label 'Demineralized Bone Matrix.' The Tissue Segment provides processing of mineralized weight-bearing allograft bone tissue. Other business units provide marketing and distributing metal spinal implant products and processing, marketing and distributing bovine tissue products. Products and services are marketed primarily to the orthopaedic, spinal, neurological, oral/maxillofacial, dental and general surgery customers in the United States, Europe and Asia.
Competitor Analysis
This analysis compares Osteotech, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
